Sarjan Shah

Sarjan Shah is the Chief Operating Officer at Auritec Pharmaceuticals, a rapidly growing drug delivery company. In this role, he oversees all product development, business development, intellectual property development, and regulatory affairs activities. Sarjan has co-authored award-winning federal grants and INDs for first-in-human clinical trials across a broad range of disease indications, including but not limited to, women’s health, infectious diseases (HIV, HSV), opioid addiction, and organ transplantation. In collaboration with the CEO, Sarjan leads Auritec’s initiatives from product ideation through proof-of-concept clinical studies.

On a day-to-day basis, Sarjan is responsible for directing the company’s laboratory staff and administrative personnel along with conceptualizing and executing his own projects that span across target product profile design, nonclinical studies, regulatory submissions, grant writing, and serving as the central point of contact for vendors, collaborators, partners, and regulatory agencies. Through his 8+ years of work experience and resulting accomplishments, Sarjan has developed unique expertise in early-stage development of 505(b)(2) sustained release drug products.

Prior to joining Auritec, he worked as a Business Analyst/Consultant for multiple life science advisory firms where he collaborated with senior consultants to co-develop actionable reimbursement, market access and business development strategies/tactics for Fortune 500 and Mid-sized pharma, biotech and medical device/diagnostic clients.

Sarjan graduated with a Master of Business and Science degree from the Keck Graduate Institute and has a Bachelor’s degree in biotechnology engineering at the University of Mumbai.